The authors did not state how the data were extracted for the review, or how many reviewers performed the data extraction. Data were extracted on the patient characteristics, intervention details and results.
Methods of synthesis
How were the studies combined? A narrative synthesis of the results was undertaken.
How were differences between studies investigated? Heterogeneity was not assessed.
Results of the review
The authors identified one study pertaining to the first question, three publications (two studies) and one unpublished study relating to the second question, one study for the third question and one report for to the fourth question.
1. Can massage improve insulin absorption, e.g. by increasing serum insulin in type 1 diabetes or increasing tissue insulin sensitivity in type 2 diabetes?
In a study of 8 well-controlled patients with type 1 diabetes who massaged their insulin injection sites with an electric vibrator for 3 minutes at 15 minutes post-injection, the patients experienced higher insulin levels and lower serum glucose levels by 15 minutes after the start of massage, although the changes were not statistically significant. However, serum glucose levels were 8.3% lower (P<0.05) 30 minutes after massage, compared with the control day when participants did not massage their injection sites. The difference in glucose levels was even more striking at 45 minutes post-massage: 76 mg/dL (+/-6%) versus 89 mg/dL (+/-4%) for the control day. After 3 to 6 months of massage, the mean HbA1 for these 8 patients and 18 others (who had been massaging their injections sites for 3 minutes at each meal) fell from 10.56% (+/-1.73) to 8.55% (+/-1.69). After 12 to 18 months, 8 patients had mean HbA1 levels of less than 8.2% (normal HbA1 level according to the laboratory assay used) and 18 patients had mean HbA1 levels of 8.41% (+/-1.58); this improvement from baseline was significant (P<0.001).
Can massage help normalise blood glucose levels?
A single-group pre-test post-test study reported that after one month of parents administering nightly full-body massage to their children with diabetes (n=14), the children's glucose levels decreased from an average of 158 to 118 mg/dL. Both the parents' and children's anxiety and depression levels decreased immediately after massage. However, the primary study authors did not state how the outcomes were measured. In another single-group pre-test post-test study, the clinical staff were trained to administer 15-minute sessions of breathing instruction, light touch and acupressure to 12 diabetic patients for 6 consecutive weeks. The patients experienced a reduction in blood glucose, anxiety, headaches, depression, work stress and anger. Self-reports also indicated that patients were sleeping better and had improved relations with their families. Statistical significance was not evaluated and the primary study authors did not state how or when the outcomes were measured.
There were unpublished preliminary data from a small randomised controlled trial that compared people with type 2 diabetes receiving 45 minutes' full-body massage three times a week for 12 weeks (n=6) to similar patients on a waiting list for massage (n=2). HbAlc decreased in 3 of the 6 patients receiving massage, from a baseline of 7.9, 8.3 and 9.8% to 7.3, 8.1 and 8.6%, respectively; in the other 3 patients it increased from 7.4, 8.2 and 8.0% to 7.9, 10.0 and 8.5%, respectively. However, the characteristics of the patients whose HbA1c increased were different from those whose HbA1c decreased. In the waiting list control group, the HbA1c level also declined from 7.3 and 8.6% to 6.9 and 8.4%, respectively.
3. Can massage provide relief of symptoms associated with diabetic neuropathy?
A single-group pre-test post-test study assessed 25 patients with symmetrical diabetic neuropathy of the lower extremities, whose duration of symptoms averaged 14 months. All of the patients received syncardial massage, a mechanical leg massage, every 2 days with the total number of treatments ranging from 10 to 30. After one month, 56% cases reported a good response, 32% reported an improvement in symptoms and 12% reported no effect.
